Diagnostic value of natriuretic peptides in pediatrics

Abstract

Natriuretic peptide hormones are the family of vasoactive substanses produced by cardiomyocytes in response to the expansion and increased pressure in the heart chambers. The review of the literature focuses on the diagnostic role of natriuretic peptides in pediatrics. The most important clinical effects of natriuretic peptides, brief history of their discovery and studying, age-related changes of serum levels are analyzed. Data of their use in the diagnosis and cardiac function monitoring in various forms of cardiomyopathy, myocardial inflammatory diseases, Kawasaki disease in children are presented. The results of studies examining the natriuretic peptides levels in children with congenital heart defects and heart transplantation in pre-and postoperative period are reviewed. The review involved the diagnostic use of natriuretic peptides in neonates, including high pulmonary hypertension and hemodynamically significant patent ductus arteriosus diagnosis in preterm infants. The possibility of the natriuretic peptides use for assessing the cardiotoxic complications risk in anti-tumor chemotherapy and for differential diagnosis of acute dyspnea due to heart failure or pulmonary diseases are discussed.

Keywords

natriuretic peptides / cardiovascular system / pediatrics

References

[1] Голухова Е.З., Алиева А.М. Клиническое значение определения натрийуретических пептидов у больных с хронической сердечной недостаточностью // Кардиол. и сердеч.-сосуд. хирург. - 2007. - Т. 47, №1. - С. 45-51.

[2] Елисеев О.М. Натрийуретические пептиды. Эволюция знаний // Терап. арх. - 2003. - Т. 75, №9. - С. 40-45.

[3] Benedictis F., Colaneri M., Osimani P. et al. Amino-terminal Pro-B-type natriuretic peptide in refractory Kawasaki disease // Pediatr. Cardiol. - 2009. - N 6. - Р. 837-839.

[4] Bernus A., Wagner B., Accurso F. et al. Brain natriuretic peptide levels in managing pediatric patients with pulmonary arterial hypertension // Chest. - 2009. - Vol. 135, N 3. - P. 745-751.

[5] Brito D., Matias J.S., Sargento L. et al. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy // Rev. Port. Cardiol. - 2004. - Vol. 23. - P. 1557-1582.

[6] Buddhe S., Dhuper S., Kim R. et al. NT-proBNP levels improve the ability of predicting a hemodynamically significant patent ductus arteriosus in very low-birth-weight infants // J. Clin. Neonatol. - 2012. - Vol. 1, N 2. - P. 82-86.

[7] Cohen S., Springer C., Avital A. Amino-terminal Pro-brain-type natriuretic peptide: heart or lung disease in pediatric respiratory distress? // Pediatrics. - 2005. - Vol. 115, N 5. - P. 1347-1350.

[8] Cho S., Kim Y., Cha S. et al. Adjuvant laboratory marker of Kawasaki disease; NT-pro-BNP or hs-CRP? // Ann. Clin. Lab. Sci. - 2011. - Vol. 41. - P. 360-363.

[9] De Bold A., Borenstein H., Veress A., Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats // Life Sci. - 1981. - Vol. 28. - P. 89-94.

[10] Eerola A., Jokinen E., Boldt T. The influence of percutaneous closure of patent ductus arteriosus on left ventricular size and function // J. Am. Coll. Cardiol. - 2006. - Vol. 47. - P. 1060-1066.

[11] El-Khuffash A., Amoruso M., Culliton M. N-terminal pro-B-type natriuretic peptide as a marker of ductal haemodynamic significance in preterm infants: a prospective observational study // Arch. Dis. Child. Fetal Neonatal Ed. - 2007. - Vol. 92. - P. 421-422.

[12] El-Khuffash A., Molloy E. Are B-type natriuretic peptide (BNP) and N-terminal-pro-BNP useful in neonates? // Arch. Dis. Child Fetal Neonatal Ed. - 2007. - Vol. 92. - P. 320-324.

[13] Farombi-Oghuvbu I., Matthews T., Mayne P. et al. N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus // Arch. Dis. Child Fetal. Neonatal. Ed. - 2008. - Vol. 93, N 4. - P. 257-260.

[14] Gessler P., Knirsch W., Schmitt B. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in children with congenital heart defects and open-heart surgery // J. Pediatr. - 2006. - Vol. 148. - P. 372-376.

[15] Guidelines for the diagnosis and treatment of chronic heart failure. Task force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology // Eur. Heart J. - 2001. - Vol. 22, N 17. - P. 1527-1560.

[16] Hammerer-Lercher A., Geiger R., Mair J. et al. Utility of N-terminal Pro-B-type natriuretic peptide to differentiate cardiac diseases from noncardiac diseases in young pediatric patients // Clin. Chem. - 2006. - Vol. 52, N 7. - Р. 1415-1419.

[17] Hunt P.J., Yandle T.G., Nicholls M.G. et al. The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma // Biochem. Biophys. Res. Commun. - 1995. - Vol. 214. - P. 1175-1183

[18] Januzzi J.L. Natriuretic peptide testing: a window into the diagnosis and prognosis of heart failure // Cleveland. Clin. J. Med. - 2006. - Vol. 73. - P. 149-157.

[19] Kaneko K., Yoshimura K., Ohashi A. et al. Prediction of the risk of coronary arterial lesions in Kawasaki disease by brain natriuretic peptide // Pediatr. Cardiol. - 2011. - Vol. 8. - P. 1106-1109.

[20] Knecht K., Alexander M., Swearingen C. et al. NTproBNP as a marker of rejection in pediatric heart transplant recipients // Pediatr. Transplant. - 2012. - Vol. 16, N 4. - P. 335-339.

[21] Koch A., Zink S., Singer H. B-type natriuretic peptide in paediatric patients with congenital heart disease // Eur. Heart J. - 2006. - Vol. 27. - P. 861-866.

[22] Lammers A., Hislop A., Haworth S. Prognostic value of B-type natriuretic peptide in children with pulmonary hypertension // Int. J. Cardiol. - 2009. - Vol. 135, N 1. - P. 21-26.

[23] Lechner E., Wiesinger-Eidenberger G., Wagner O. Amino terminal pro B-type natriuretic peptide levels are elevated in the cord blood of neonates with congenital heart defect // Pediatr. Res. - 2009. - Vol. 66. - P. 466-469.

[24] Lipshultz S., Miller T., Scully R. Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes // J. Clin. Oncol. - 2012. - Vol. 30. - P. 1042-1049.

[25] Maher K.O., Reed H., Cuadrado F., Simsic J. B-type natriuretic peptide in the emergency diagnosis of critical heart disease in children // Pediatrics. - 2008. - Vol. 121. - P. 1484-1488.

[26] Mukoyama M., Nakao K., Hosoda K. et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide // J. Clin. Invest. - 1991. - Vol. 87. - P. 1402-1412.

[27] Nasser N., Perles Z., Rein A.J., Nir A. NT-proBNP as a marker for persistent cardiac disease in children with history of dilated cardiomyopathy and myocarditis // Pediatr. Cardiol. - 2006. - Vol. 27. - P. 87-90.

[28] Nir A., Lindinger A., Rauh M. et al. NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies // B. Pediatr. Cardiol. - 2009. - Vol. 30. - P. 3-8.

[29] Nir A., Nasser N. Clinical value of NT-ProBNP and BNP in pediatric cardiology // J. Cardiac. Failure. - 2005. - N 5. - Р. 76-80.

[30] Norozi K., Buchhorn R., Kaiser C. Plasma N-terminal Pro-brain natriuretic peptide as a marker of right ventricular dysfunction in patients with tetralogy of fallot after surgical repair // Chest. - 2005. - Vol. 128, N 4. - P. 2563-2570.

[31] Potter L.R., Abbey-Hosch S., Dickey D.M. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions // Endocr. Reviews. - 2006. - Vol. 27, N 1. - P. 47-72.

[32] Price J., Price A., Thomas K. et al. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction // Circulation. - 2006. - Vol. 114, N 10. - P. 1063-1069.

[33] Reynolds E.W., Ellington J.G., Vranicar M. Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn // Pediatrics. - 2004. - Vol. 114, N 5. - P. 1297-1304.

[34] Rusconi P., Ludwig D., Sandhu S. et al. Cross validation of NT-proBNP as a predictor of cardiac transplant in children with dilated cardiomyopathy // J. Amer. Coll. Cardiol. - 2011. - Vol. 14. - P. 425.

[35] Schoena S., Zimmermanna T., Kittnerb T. NT-proBNP correlates with right heart haemodynamic parameters and volumes in patients with atrial septal defects // Eur. J. Heart Fail. - 2007. - Vol. 9. - P. 660-666.

[36] Sezgin E.M., Ucar B., Kilic Z., Colak O. The value of serum N-terminal pro-brain natriuretic peptide levels in the differential diagnosis and follow-up of congestive cardiac failure and respiratory distress due to pulmonary aetiologies in infants and children // Cardiol. Young. - 2010. - Vol. 20, N 5. - P. 495-504.

[37] Shah A., Feraco A., Harmon C., Tacy T. Usefulness of various plasma biomarkers for diagnosis of heart failure in children with single ventricle physiology // Am. J. Cardiol. - 2009. - Vol. 104. - P. 1280-1284.

[38] Soker M., Kervancioglu M. Plasma concentrations of NT-pro-BNP and cardiac troponin-I in relation to doxorubicin-induced cardiomyopathy and cardiac function in childhood malignancy // Saudi. Med. J. - 2005. - Vol. 26, N 8. - P. 1197-1202.

[39] Sudoh T., Kangawa K., Minamino N., Matsuo H. A new natriuretic peptide in porcine brain // Nature. - 1988. - N 332. - P. 78-81.

[40] Vijlbrief D., Benders M., Kemperman H. et al. Use of cardiac biomarkers in neonatology // Pediatr. Res. - 2012. - Vol. 72. - P. 337-343.

[41] Walsh R., Boyer C., LaCorte J. N-terminal B-type natriuretic peptide levels in pediatric patients with congestive heart failure undergoing cardiac surgery // J. Thorac. Cardiovasc. Surg. - 2008. - Vol. 135. - P. 98-105.

[42] Welisch E., Kleesiek K., Haas N. Aminoterminal ProB-type natriuretic peptide (NT-proBNP) levels for monitoring interventions in paediatric cardiac patients with stenotic lesions // Intern. J. Pediatr. - 2009. - Vol. 1. - P. 6-12.

[43] Wu Y., Chen S., Huang M. Diagnostic value of plasma concentration of pro-brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects // Zhonghua Er Ke Za Zhi. - 2005. - Vol. 43. - P. 161-164.

[44] Zhang Q., Du J., Chen Y., Li W. Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice // Zhonghua Er Ke Za Zhi. - 2006. - Vol. 44. - P. 886-890.

RIGHTS & PERMISSIONS

Saidova V.T.